nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CYP3A4—bone cancer	0.291	0.505	CbGaD
Celecoxib—PTGS2—bone cancer	0.285	0.495	CbGaD
Celecoxib—ABCC4—Methotrexate—bone cancer	0.0486	0.346	CbGbCtD
Celecoxib—PTGS2—Cisplatin—bone cancer	0.044	0.313	CbGbCtD
Celecoxib—ALB—Methotrexate—bone cancer	0.018	0.128	CbGbCtD
Celecoxib—CYP2C9—Cisplatin—bone cancer	0.015	0.106	CbGbCtD
Celecoxib—CYP2D6—Doxorubicin—bone cancer	0.00917	0.0652	CbGbCtD
Celecoxib—CYP3A4—Doxorubicin—bone cancer	0.00583	0.0415	CbGbCtD
Celecoxib—Etoricoxib—CYP3A4—bone cancer	0.00174	0.505	CrCbGaD
Celecoxib—Etoricoxib—PTGS2—bone cancer	0.0017	0.495	CrCbGaD
Celecoxib—ORM1—vertebral column—bone cancer	0.00156	0.122	CbGeAlD
Celecoxib—CA2—periosteum—bone cancer	0.00122	0.0956	CbGeAlD
Celecoxib—PTGS2—periosteum—bone cancer	0.000898	0.0705	CbGeAlD
Celecoxib—PTGS2—leg—bone cancer	0.000716	0.0562	CbGeAlD
Celecoxib—PDPK1—spinal cord—bone cancer	0.000675	0.053	CbGeAlD
Celecoxib—PTGS2—hindlimb—bone cancer	0.000639	0.0502	CbGeAlD
Celecoxib—PTGS2—cartilage tissue—bone cancer	0.000629	0.0494	CbGeAlD
Celecoxib—PTGS2—appendage—bone cancer	0.000548	0.0431	CbGeAlD
Celecoxib—MAPK14—connective tissue—bone cancer	0.000544	0.0428	CbGeAlD
Celecoxib—CA12—connective tissue—bone cancer	0.000413	0.0324	CbGeAlD
Celecoxib—CA9—tendon—bone cancer	0.000384	0.0301	CbGeAlD
Celecoxib—MAPK14—tendon—bone cancer	0.000374	0.0294	CbGeAlD
Celecoxib—CA14—tendon—bone cancer	0.000364	0.0286	CbGeAlD
Celecoxib—MAPK14—bone marrow—bone cancer	0.000362	0.0285	CbGeAlD
Celecoxib—MAPK14—spinal cord—bone cancer	0.000361	0.0283	CbGeAlD
Celecoxib—CA14—spinal cord—bone cancer	0.000351	0.0276	CbGeAlD
Celecoxib—CA5B—tendon—bone cancer	0.000255	0.02	CbGeAlD
Celecoxib—ORM1—bone marrow—bone cancer	0.000218	0.0171	CbGeAlD
Celecoxib—ORM1—spinal cord—bone cancer	0.000217	0.0171	CbGeAlD
Celecoxib—CA2—connective tissue—bone cancer	0.000212	0.0167	CbGeAlD
Celecoxib—ABCC4—tendon—bone cancer	0.000191	0.015	CbGeAlD
Celecoxib—ABCC4—bone marrow—bone cancer	0.000185	0.0145	CbGeAlD
Celecoxib—CA4—tendon—bone cancer	0.000176	0.0138	CbGeAlD
Celecoxib—Stomatitis—Epirubicin—bone cancer	0.000172	0.00113	CcSEcCtD
Celecoxib—Jaundice—Epirubicin—bone cancer	0.000172	0.00113	CcSEcCtD
Celecoxib—Urinary tract infection—Epirubicin—bone cancer	0.000171	0.00113	CcSEcCtD
Celecoxib—Conjunctivitis—Epirubicin—bone cancer	0.000171	0.00113	CcSEcCtD
Celecoxib—Dysuria—Doxorubicin—bone cancer	0.000171	0.00113	CcSEcCtD
Celecoxib—CA4—bone marrow—bone cancer	0.00017	0.0134	CbGeAlD
Celecoxib—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00017	0.00112	CcSEcCtD
Celecoxib—Haemoglobin—Methotrexate—bone cancer	0.00017	0.00112	CcSEcCtD
Celecoxib—CA4—spinal cord—bone cancer	0.000169	0.0133	CbGeAlD
Celecoxib—Haemorrhage—Methotrexate—bone cancer	0.000169	0.00112	CcSEcCtD
Celecoxib—Hepatitis—Methotrexate—bone cancer	0.000169	0.00112	CcSEcCtD
Celecoxib—Pollakiuria—Doxorubicin—bone cancer	0.000169	0.00112	CcSEcCtD
Celecoxib—Haematuria—Epirubicin—bone cancer	0.000168	0.00111	CcSEcCtD
Celecoxib—Pharyngitis—Methotrexate—bone cancer	0.000168	0.00111	CcSEcCtD
Celecoxib—Urinary tract disorder—Methotrexate—bone cancer	0.000167	0.0011	CcSEcCtD
Celecoxib—Photosensitivity reaction—Doxorubicin—bone cancer	0.000167	0.0011	CcSEcCtD
Celecoxib—Hepatobiliary disease—Epirubicin—bone cancer	0.000167	0.0011	CcSEcCtD
Celecoxib—Weight increased—Doxorubicin—bone cancer	0.000166	0.0011	CcSEcCtD
Celecoxib—Epistaxis—Epirubicin—bone cancer	0.000166	0.0011	CcSEcCtD
Celecoxib—Urethral disorder—Methotrexate—bone cancer	0.000166	0.00109	CcSEcCtD
Celecoxib—Sinusitis—Epirubicin—bone cancer	0.000165	0.00109	CcSEcCtD
Celecoxib—Hyperglycaemia—Doxorubicin—bone cancer	0.000165	0.00109	CcSEcCtD
Celecoxib—Agranulocytosis—Epirubicin—bone cancer	0.000164	0.00109	CcSEcCtD
Celecoxib—Pneumonia—Doxorubicin—bone cancer	0.000164	0.00108	CcSEcCtD
Celecoxib—Infestation NOS—Doxorubicin—bone cancer	0.000163	0.00108	CcSEcCtD
Celecoxib—Infestation—Doxorubicin—bone cancer	0.000163	0.00108	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000162	0.00107	CcSEcCtD
Celecoxib—Hypersensitivity—Cisplatin—bone cancer	0.000161	0.00106	CcSEcCtD
Celecoxib—Erythema multiforme—Methotrexate—bone cancer	0.00016	0.00106	CcSEcCtD
Celecoxib—Neuropathy peripheral—Doxorubicin—bone cancer	0.00016	0.00106	CcSEcCtD
Celecoxib—Haemoglobin—Epirubicin—bone cancer	0.000159	0.00105	CcSEcCtD
Celecoxib—Jaundice—Doxorubicin—bone cancer	0.000159	0.00105	CcSEcCtD
Celecoxib—Stomatitis—Doxorubicin—bone cancer	0.000159	0.00105	CcSEcCtD
Celecoxib—Rhinitis—Epirubicin—bone cancer	0.000159	0.00105	CcSEcCtD
Celecoxib—Conjunctivitis—Doxorubicin—bone cancer	0.000158	0.00105	CcSEcCtD
Celecoxib—Urinary tract infection—Doxorubicin—bone cancer	0.000158	0.00105	CcSEcCtD
Celecoxib—Haemorrhage—Epirubicin—bone cancer	0.000158	0.00104	CcSEcCtD
Celecoxib—Hepatitis—Epirubicin—bone cancer	0.000158	0.00104	CcSEcCtD
Celecoxib—Eye disorder—Methotrexate—bone cancer	0.000158	0.00104	CcSEcCtD
Celecoxib—Tinnitus—Methotrexate—bone cancer	0.000158	0.00104	CcSEcCtD
Celecoxib—Hypoaesthesia—Epirubicin—bone cancer	0.000157	0.00104	CcSEcCtD
Celecoxib—Asthenia—Cisplatin—bone cancer	0.000157	0.00104	CcSEcCtD
Celecoxib—Pharyngitis—Epirubicin—bone cancer	0.000157	0.00104	CcSEcCtD
Celecoxib—Cardiac disorder—Methotrexate—bone cancer	0.000157	0.00104	CcSEcCtD
Celecoxib—PTGS2—connective tissue—bone cancer	0.000157	0.0123	CbGeAlD
Celecoxib—Urinary tract disorder—Epirubicin—bone cancer	0.000156	0.00103	CcSEcCtD
Celecoxib—Oedema peripheral—Epirubicin—bone cancer	0.000156	0.00103	CcSEcCtD
Celecoxib—Haematuria—Doxorubicin—bone cancer	0.000155	0.00103	CcSEcCtD
Celecoxib—Connective tissue disorder—Epirubicin—bone cancer	0.000155	0.00103	CcSEcCtD
Celecoxib—Urethral disorder—Epirubicin—bone cancer	0.000155	0.00102	CcSEcCtD
Celecoxib—Hepatobiliary disease—Doxorubicin—bone cancer	0.000154	0.00102	CcSEcCtD
Celecoxib—Epistaxis—Doxorubicin—bone cancer	0.000154	0.00102	CcSEcCtD
Celecoxib—Angiopathy—Methotrexate—bone cancer	0.000153	0.00101	CcSEcCtD
Celecoxib—Sinusitis—Doxorubicin—bone cancer	0.000153	0.00101	CcSEcCtD
Celecoxib—Immune system disorder—Methotrexate—bone cancer	0.000153	0.00101	CcSEcCtD
Celecoxib—Mediastinal disorder—Methotrexate—bone cancer	0.000152	0.00101	CcSEcCtD
Celecoxib—Agranulocytosis—Doxorubicin—bone cancer	0.000152	0.001	CcSEcCtD
Celecoxib—Diarrhoea—Cisplatin—bone cancer	0.00015	0.000989	CcSEcCtD
Celecoxib—Erythema multiforme—Epirubicin—bone cancer	0.00015	0.000987	CcSEcCtD
Celecoxib—Alopecia—Methotrexate—bone cancer	0.000149	0.000986	CcSEcCtD
Celecoxib—Mental disorder—Methotrexate—bone cancer	0.000148	0.000978	CcSEcCtD
Celecoxib—Eye disorder—Epirubicin—bone cancer	0.000148	0.000976	CcSEcCtD
Celecoxib—Tinnitus—Epirubicin—bone cancer	0.000147	0.000974	CcSEcCtD
Celecoxib—Haemoglobin—Doxorubicin—bone cancer	0.000147	0.000971	CcSEcCtD
Celecoxib—Flushing—Epirubicin—bone cancer	0.000147	0.000969	CcSEcCtD
Celecoxib—Cardiac disorder—Epirubicin—bone cancer	0.000147	0.000969	CcSEcCtD
Celecoxib—Rhinitis—Doxorubicin—bone cancer	0.000147	0.000969	CcSEcCtD
Celecoxib—Hepatitis—Doxorubicin—bone cancer	0.000146	0.000966	CcSEcCtD
Celecoxib—Haemorrhage—Doxorubicin—bone cancer	0.000146	0.000966	CcSEcCtD
Celecoxib—CA2—tendon—bone cancer	0.000146	0.0114	CbGeAlD
Celecoxib—Hypoaesthesia—Doxorubicin—bone cancer	0.000146	0.000961	CcSEcCtD
Celecoxib—Pharyngitis—Doxorubicin—bone cancer	0.000145	0.000959	CcSEcCtD
Celecoxib—Urinary tract disorder—Doxorubicin—bone cancer	0.000145	0.000954	CcSEcCtD
Celecoxib—Oedema peripheral—Doxorubicin—bone cancer	0.000144	0.000952	CcSEcCtD
Celecoxib—Dysgeusia—Methotrexate—bone cancer	0.000144	0.000951	CcSEcCtD
Celecoxib—Connective tissue disorder—Doxorubicin—bone cancer	0.000144	0.00095	CcSEcCtD
Celecoxib—Angiopathy—Epirubicin—bone cancer	0.000144	0.000948	CcSEcCtD
Celecoxib—Urethral disorder—Doxorubicin—bone cancer	0.000143	0.000947	CcSEcCtD
Celecoxib—Immune system disorder—Epirubicin—bone cancer	0.000143	0.000943	CcSEcCtD
Celecoxib—Mediastinal disorder—Epirubicin—bone cancer	0.000143	0.000941	CcSEcCtD
Celecoxib—Back pain—Methotrexate—bone cancer	0.000142	0.00094	CcSEcCtD
Celecoxib—Arrhythmia—Epirubicin—bone cancer	0.000141	0.000933	CcSEcCtD
Celecoxib—CA2—bone marrow—bone cancer	0.000141	0.0111	CbGeAlD
Celecoxib—CA2—spinal cord—bone cancer	0.000141	0.011	CbGeAlD
Celecoxib—Alopecia—Epirubicin—bone cancer	0.00014	0.000923	CcSEcCtD
Celecoxib—Vomiting—Cisplatin—bone cancer	0.000139	0.000919	CcSEcCtD
Celecoxib—Vision blurred—Methotrexate—bone cancer	0.000139	0.000916	CcSEcCtD
Celecoxib—Mental disorder—Epirubicin—bone cancer	0.000139	0.000915	CcSEcCtD
Celecoxib—Erythema multiforme—Doxorubicin—bone cancer	0.000138	0.000914	CcSEcCtD
Celecoxib—Rash—Cisplatin—bone cancer	0.000138	0.000911	CcSEcCtD
Celecoxib—Dermatitis—Cisplatin—bone cancer	0.000138	0.00091	CcSEcCtD
Celecoxib—Eye disorder—Doxorubicin—bone cancer	0.000137	0.000903	CcSEcCtD
Celecoxib—Tinnitus—Doxorubicin—bone cancer	0.000136	0.000901	CcSEcCtD
Celecoxib—Anaemia—Methotrexate—bone cancer	0.000136	0.000898	CcSEcCtD
Celecoxib—Flushing—Doxorubicin—bone cancer	0.000136	0.000897	CcSEcCtD
Celecoxib—Cardiac disorder—Doxorubicin—bone cancer	0.000136	0.000897	CcSEcCtD
Celecoxib—Flatulence—Epirubicin—bone cancer	0.000136	0.000896	CcSEcCtD
Celecoxib—Tension—Epirubicin—bone cancer	0.000135	0.000892	CcSEcCtD
Celecoxib—Dysgeusia—Epirubicin—bone cancer	0.000135	0.00089	CcSEcCtD
Celecoxib—Nervousness—Epirubicin—bone cancer	0.000134	0.000883	CcSEcCtD
Celecoxib—Back pain—Epirubicin—bone cancer	0.000133	0.000879	CcSEcCtD
Celecoxib—Angiopathy—Doxorubicin—bone cancer	0.000133	0.000877	CcSEcCtD
Celecoxib—Muscle spasms—Epirubicin—bone cancer	0.000132	0.000874	CcSEcCtD
Celecoxib—Immune system disorder—Doxorubicin—bone cancer	0.000132	0.000873	CcSEcCtD
Celecoxib—Vertigo—Methotrexate—bone cancer	0.000132	0.000873	CcSEcCtD
Celecoxib—Mediastinal disorder—Doxorubicin—bone cancer	0.000132	0.000871	CcSEcCtD
Celecoxib—Leukopenia—Methotrexate—bone cancer	0.000132	0.00087	CcSEcCtD
Celecoxib—Arrhythmia—Doxorubicin—bone cancer	0.000131	0.000863	CcSEcCtD
Celecoxib—Nausea—Cisplatin—bone cancer	0.00013	0.000858	CcSEcCtD
Celecoxib—Vision blurred—Epirubicin—bone cancer	0.00013	0.000857	CcSEcCtD
Celecoxib—Alopecia—Doxorubicin—bone cancer	0.000129	0.000854	CcSEcCtD
Celecoxib—Cough—Methotrexate—bone cancer	0.000128	0.000848	CcSEcCtD
Celecoxib—Mental disorder—Doxorubicin—bone cancer	0.000128	0.000847	CcSEcCtD
Celecoxib—Anaemia—Epirubicin—bone cancer	0.000127	0.00084	CcSEcCtD
Celecoxib—Flatulence—Doxorubicin—bone cancer	0.000126	0.000829	CcSEcCtD
Celecoxib—Arthralgia—Methotrexate—bone cancer	0.000125	0.000827	CcSEcCtD
Celecoxib—Myalgia—Methotrexate—bone cancer	0.000125	0.000827	CcSEcCtD
Celecoxib—Chest pain—Methotrexate—bone cancer	0.000125	0.000827	CcSEcCtD
Celecoxib—Tension—Doxorubicin—bone cancer	0.000125	0.000825	CcSEcCtD
Celecoxib—Dysgeusia—Doxorubicin—bone cancer	0.000125	0.000824	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000124	0.000821	CcSEcCtD
Celecoxib—Nervousness—Doxorubicin—bone cancer	0.000124	0.000817	CcSEcCtD
Celecoxib—Vertigo—Epirubicin—bone cancer	0.000124	0.000817	CcSEcCtD
Celecoxib—Syncope—Epirubicin—bone cancer	0.000123	0.000815	CcSEcCtD
Celecoxib—Leukopenia—Epirubicin—bone cancer	0.000123	0.000814	CcSEcCtD
Celecoxib—Back pain—Doxorubicin—bone cancer	0.000123	0.000814	CcSEcCtD
Celecoxib—Muscle spasms—Doxorubicin—bone cancer	0.000122	0.000809	CcSEcCtD
Celecoxib—Palpitations—Epirubicin—bone cancer	0.000122	0.000803	CcSEcCtD
Celecoxib—Confusional state—Methotrexate—bone cancer	0.000121	0.000799	CcSEcCtD
Celecoxib—Loss of consciousness—Epirubicin—bone cancer	0.000121	0.000799	CcSEcCtD
Celecoxib—Cough—Epirubicin—bone cancer	0.00012	0.000793	CcSEcCtD
Celecoxib—Anaphylactic shock—Methotrexate—bone cancer	0.00012	0.000793	CcSEcCtD
Celecoxib—Vision blurred—Doxorubicin—bone cancer	0.00012	0.000793	CcSEcCtD
Celecoxib—Infection—Methotrexate—bone cancer	0.000119	0.000788	CcSEcCtD
Celecoxib—Hypertension—Epirubicin—bone cancer	0.000119	0.000785	CcSEcCtD
Celecoxib—Nervous system disorder—Methotrexate—bone cancer	0.000118	0.000778	CcSEcCtD
Celecoxib—Anaemia—Doxorubicin—bone cancer	0.000118	0.000778	CcSEcCtD
Celecoxib—Thrombocytopenia—Methotrexate—bone cancer	0.000118	0.000776	CcSEcCtD
Celecoxib—Myalgia—Epirubicin—bone cancer	0.000117	0.000774	CcSEcCtD
Celecoxib—Chest pain—Epirubicin—bone cancer	0.000117	0.000774	CcSEcCtD
Celecoxib—Arthralgia—Epirubicin—bone cancer	0.000117	0.000774	CcSEcCtD
Celecoxib—Anxiety—Epirubicin—bone cancer	0.000117	0.000771	CcSEcCtD
Celecoxib—Skin disorder—Methotrexate—bone cancer	0.000117	0.00077	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000116	0.000769	CcSEcCtD
Celecoxib—Hyperhidrosis—Methotrexate—bone cancer	0.000116	0.000766	CcSEcCtD
Celecoxib—Dry mouth—Epirubicin—bone cancer	0.000115	0.000757	CcSEcCtD
Celecoxib—Vertigo—Doxorubicin—bone cancer	0.000114	0.000756	CcSEcCtD
Celecoxib—Anorexia—Methotrexate—bone cancer	0.000114	0.000756	CcSEcCtD
Celecoxib—Syncope—Doxorubicin—bone cancer	0.000114	0.000754	CcSEcCtD
Celecoxib—Leukopenia—Doxorubicin—bone cancer	0.000114	0.000753	CcSEcCtD
Celecoxib—Confusional state—Epirubicin—bone cancer	0.000113	0.000748	CcSEcCtD
Celecoxib—Palpitations—Doxorubicin—bone cancer	0.000113	0.000743	CcSEcCtD
Celecoxib—Anaphylactic shock—Epirubicin—bone cancer	0.000112	0.000742	CcSEcCtD
Celecoxib—Oedema—Epirubicin—bone cancer	0.000112	0.000742	CcSEcCtD
Celecoxib—Loss of consciousness—Doxorubicin—bone cancer	0.000112	0.000739	CcSEcCtD
Celecoxib—Infection—Epirubicin—bone cancer	0.000112	0.000737	CcSEcCtD
Celecoxib—Cough—Doxorubicin—bone cancer	0.000111	0.000734	CcSEcCtD
Celecoxib—Shock—Epirubicin—bone cancer	0.000111	0.00073	CcSEcCtD
Celecoxib—Nervous system disorder—Epirubicin—bone cancer	0.00011	0.000728	CcSEcCtD
Celecoxib—Thrombocytopenia—Epirubicin—bone cancer	0.00011	0.000726	CcSEcCtD
Celecoxib—Hypertension—Doxorubicin—bone cancer	0.00011	0.000726	CcSEcCtD
Celecoxib—Tachycardia—Epirubicin—bone cancer	0.00011	0.000724	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000109	0.000722	CcSEcCtD
Celecoxib—Skin disorder—Epirubicin—bone cancer	0.000109	0.000721	CcSEcCtD
Celecoxib—Hyperhidrosis—Epirubicin—bone cancer	0.000109	0.000717	CcSEcCtD
Celecoxib—Insomnia—Methotrexate—bone cancer	0.000109	0.000717	CcSEcCtD
Celecoxib—Chest pain—Doxorubicin—bone cancer	0.000108	0.000716	CcSEcCtD
Celecoxib—Arthralgia—Doxorubicin—bone cancer	0.000108	0.000716	CcSEcCtD
Celecoxib—Myalgia—Doxorubicin—bone cancer	0.000108	0.000716	CcSEcCtD
Celecoxib—Anxiety—Doxorubicin—bone cancer	0.000108	0.000714	CcSEcCtD
Celecoxib—Paraesthesia—Methotrexate—bone cancer	0.000108	0.000712	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000108	0.000711	CcSEcCtD
Celecoxib—PTGS2—tendon—bone cancer	0.000108	0.00845	CbGeAlD
Celecoxib—Anorexia—Epirubicin—bone cancer	0.000107	0.000707	CcSEcCtD
Celecoxib—Dyspnoea—Methotrexate—bone cancer	0.000107	0.000707	CcSEcCtD
Celecoxib—Somnolence—Methotrexate—bone cancer	0.000107	0.000705	CcSEcCtD
Celecoxib—Dry mouth—Doxorubicin—bone cancer	0.000106	0.0007	CcSEcCtD
Celecoxib—Dyspepsia—Methotrexate—bone cancer	0.000106	0.000698	CcSEcCtD
Celecoxib—Confusional state—Doxorubicin—bone cancer	0.000105	0.000692	CcSEcCtD
Celecoxib—Decreased appetite—Methotrexate—bone cancer	0.000104	0.000689	CcSEcCtD
Celecoxib—PTGS2—bone marrow—bone cancer	0.000104	0.00819	CbGeAlD
Celecoxib—Oedema—Doxorubicin—bone cancer	0.000104	0.000687	CcSEcCtD
Celecoxib—Anaphylactic shock—Doxorubicin—bone cancer	0.000104	0.000687	CcSEcCtD
Celecoxib—PTGS2—spinal cord—bone cancer	0.000104	0.00815	CbGeAlD
Celecoxib—Gastrointestinal disorder—Methotrexate—bone cancer	0.000104	0.000685	CcSEcCtD
Celecoxib—Fatigue—Methotrexate—bone cancer	0.000104	0.000684	CcSEcCtD
Celecoxib—Infection—Doxorubicin—bone cancer	0.000103	0.000682	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000102	0.000676	CcSEcCtD
Celecoxib—Shock—Doxorubicin—bone cancer	0.000102	0.000675	CcSEcCtD
Celecoxib—Nervous system disorder—Doxorubicin—bone cancer	0.000102	0.000673	CcSEcCtD
Celecoxib—Thrombocytopenia—Doxorubicin—bone cancer	0.000102	0.000672	CcSEcCtD
Celecoxib—Insomnia—Epirubicin—bone cancer	0.000102	0.000671	CcSEcCtD
Celecoxib—Tachycardia—Doxorubicin—bone cancer	0.000101	0.00067	CcSEcCtD
Celecoxib—Skin disorder—Doxorubicin—bone cancer	0.000101	0.000667	CcSEcCtD
Celecoxib—Paraesthesia—Epirubicin—bone cancer	0.000101	0.000666	CcSEcCtD
Celecoxib—Hyperhidrosis—Doxorubicin—bone cancer	0.000101	0.000664	CcSEcCtD
Celecoxib—Dyspnoea—Epirubicin—bone cancer	0.0001	0.000662	CcSEcCtD
Celecoxib—Somnolence—Epirubicin—bone cancer	9.99e-05	0.00066	CcSEcCtD
Celecoxib—Anorexia—Doxorubicin—bone cancer	9.91e-05	0.000654	CcSEcCtD
Celecoxib—Feeling abnormal—Methotrexate—bone cancer	9.9e-05	0.000653	CcSEcCtD
Celecoxib—Dyspepsia—Epirubicin—bone cancer	9.89e-05	0.000653	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methotrexate—bone cancer	9.82e-05	0.000648	CcSEcCtD
Celecoxib—Decreased appetite—Epirubicin—bone cancer	9.77e-05	0.000645	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Epirubicin—bone cancer	9.7e-05	0.000641	CcSEcCtD
Celecoxib—Fatigue—Epirubicin—bone cancer	9.69e-05	0.00064	CcSEcCtD
Celecoxib—Constipation—Epirubicin—bone cancer	9.61e-05	0.000635	CcSEcCtD
Celecoxib—Urticaria—Methotrexate—bone cancer	9.54e-05	0.00063	CcSEcCtD
Celecoxib—Abdominal pain—Methotrexate—bone cancer	9.49e-05	0.000627	CcSEcCtD
Celecoxib—Body temperature increased—Methotrexate—bone cancer	9.49e-05	0.000627	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.47e-05	0.000625	CcSEcCtD
Celecoxib—Insomnia—Doxorubicin—bone cancer	9.4e-05	0.000621	CcSEcCtD
Celecoxib—Paraesthesia—Doxorubicin—bone cancer	9.34e-05	0.000616	CcSEcCtD
Celecoxib—Dyspnoea—Doxorubicin—bone cancer	9.27e-05	0.000612	CcSEcCtD
Celecoxib—Feeling abnormal—Epirubicin—bone cancer	9.26e-05	0.000611	CcSEcCtD
Celecoxib—Somnolence—Doxorubicin—bone cancer	9.24e-05	0.00061	CcSEcCtD
Celecoxib—Gastrointestinal pain—Epirubicin—bone cancer	9.19e-05	0.000607	CcSEcCtD
Celecoxib—Dyspepsia—Doxorubicin—bone cancer	9.15e-05	0.000604	CcSEcCtD
Celecoxib—Decreased appetite—Doxorubicin—bone cancer	9.04e-05	0.000597	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Doxorubicin—bone cancer	8.98e-05	0.000593	CcSEcCtD
Celecoxib—Fatigue—Doxorubicin—bone cancer	8.96e-05	0.000592	CcSEcCtD
Celecoxib—Urticaria—Epirubicin—bone cancer	8.93e-05	0.000589	CcSEcCtD
Celecoxib—Constipation—Doxorubicin—bone cancer	8.89e-05	0.000587	CcSEcCtD
Celecoxib—Abdominal pain—Epirubicin—bone cancer	8.88e-05	0.000587	CcSEcCtD
Celecoxib—Body temperature increased—Epirubicin—bone cancer	8.88e-05	0.000587	CcSEcCtD
Celecoxib—Hypersensitivity—Methotrexate—bone cancer	8.85e-05	0.000584	CcSEcCtD
Celecoxib—PDPK1—B Cell Activation—EGFR—bone cancer	8.78e-05	0.000755	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GRM4—bone cancer	8.72e-05	0.00075	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RGS1—bone cancer	8.72e-05	0.00075	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—FUS—bone cancer	8.72e-05	0.00075	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—MDM2—bone cancer	8.68e-05	0.000746	CbGpPWpGaD
Celecoxib—Asthenia—Methotrexate—bone cancer	8.62e-05	0.000569	CcSEcCtD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—JUN—bone cancer	8.61e-05	0.00074	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CDK4—bone cancer	8.6e-05	0.000739	CbGpPWpGaD
Celecoxib—Feeling abnormal—Doxorubicin—bone cancer	8.57e-05	0.000566	CcSEcCtD
Celecoxib—PDPK1—Hemostasis—PLAU—bone cancer	8.55e-05	0.000735	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—GNA11—bone cancer	8.53e-05	0.000733	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Doxorubicin—bone cancer	8.5e-05	0.000561	CcSEcCtD
Celecoxib—Pruritus—Methotrexate—bone cancer	8.5e-05	0.000561	CcSEcCtD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—JUN—bone cancer	8.44e-05	0.000726	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GNA11—bone cancer	8.41e-05	0.000723	CbGpPWpGaD
Celecoxib—PDPK1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	8.4e-05	0.000722	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CYP3A4—bone cancer	8.38e-05	0.00072	CbGpPWpGaD
Celecoxib—CA12—Metabolism—DHFR—bone cancer	8.33e-05	0.000716	CbGpPWpGaD
Celecoxib—Hypersensitivity—Epirubicin—bone cancer	8.28e-05	0.000547	CcSEcCtD
Celecoxib—Urticaria—Doxorubicin—bone cancer	8.26e-05	0.000545	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—GNA11—bone cancer	8.25e-05	0.000709	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL3—bone cancer	8.24e-05	0.000708	CbGpPWpGaD
Celecoxib—Abdominal pain—Doxorubicin—bone cancer	8.22e-05	0.000543	CcSEcCtD
Celecoxib—Body temperature increased—Doxorubicin—bone cancer	8.22e-05	0.000543	CcSEcCtD
Celecoxib—Diarrhoea—Methotrexate—bone cancer	8.22e-05	0.000542	CcSEcCtD
Celecoxib—ALB—Platelet activation, signaling and aggregation—SPARC—bone cancer	8.19e-05	0.000704	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—SPARC—bone cancer	8.17e-05	0.000702	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CYP3A4—bone cancer	8.17e-05	0.000702	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CYP3A4—bone cancer	8.17e-05	0.000702	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—RB1—bone cancer	8.13e-05	0.000699	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	8.11e-05	0.000697	CbGpPWpGaD
Celecoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.09e-05	0.000695	CbGpPWpGaD
Celecoxib—Asthenia—Epirubicin—bone cancer	8.06e-05	0.000532	CcSEcCtD
Celecoxib—PDPK1—Disease—ENO2—bone cancer	8.03e-05	0.00069	CbGpPWpGaD
Celecoxib—Pruritus—Epirubicin—bone cancer	7.95e-05	0.000525	CcSEcCtD
Celecoxib—Dizziness—Methotrexate—bone cancer	7.94e-05	0.000524	CcSEcCtD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—JUN—bone cancer	7.93e-05	0.000681	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.88e-05	0.000678	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GNA11—bone cancer	7.79e-05	0.00067	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL3—bone cancer	7.74e-05	0.000665	CbGpPWpGaD
Celecoxib—Diarrhoea—Epirubicin—bone cancer	7.69e-05	0.000508	CcSEcCtD
Celecoxib—Hypersensitivity—Doxorubicin—bone cancer	7.66e-05	0.000506	CcSEcCtD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—bone cancer	7.66e-05	0.000658	CbGpPWpGaD
Celecoxib—Vomiting—Methotrexate—bone cancer	7.63e-05	0.000504	CcSEcCtD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	7.62e-05	0.000655	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CYP3A4—bone cancer	7.62e-05	0.000655	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	7.61e-05	0.000654	CbGpPWpGaD
Celecoxib—Rash—Methotrexate—bone cancer	7.57e-05	0.0005	CcSEcCtD
Celecoxib—Dermatitis—Methotrexate—bone cancer	7.56e-05	0.000499	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—GRM1—bone cancer	7.56e-05	0.00065	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—JUN—bone cancer	7.55e-05	0.000649	CbGpPWpGaD
Celecoxib—Headache—Methotrexate—bone cancer	7.52e-05	0.000497	CcSEcCtD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—JUN—bone cancer	7.52e-05	0.000646	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—GNA11—bone cancer	7.49e-05	0.000644	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL3—bone cancer	7.48e-05	0.000643	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—RB1—bone cancer	7.47e-05	0.000643	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—GNA11—bone cancer	7.47e-05	0.000642	CbGpPWpGaD
Celecoxib—Asthenia—Doxorubicin—bone cancer	7.46e-05	0.000493	CcSEcCtD
Celecoxib—PDPK1—Disease—DHFR—bone cancer	7.45e-05	0.00064	CbGpPWpGaD
Celecoxib—Dizziness—Epirubicin—bone cancer	7.43e-05	0.000491	CcSEcCtD
Celecoxib—MAPK14—BDNF signaling pathway—JUN—bone cancer	7.39e-05	0.000636	CbGpPWpGaD
Celecoxib—Pruritus—Doxorubicin—bone cancer	7.36e-05	0.000486	CcSEcCtD
Celecoxib—CA14—Metabolism—GSTP1—bone cancer	7.17e-05	0.000616	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ENO2—bone cancer	7.16e-05	0.000616	CbGpPWpGaD
Celecoxib—Vomiting—Epirubicin—bone cancer	7.14e-05	0.000472	CcSEcCtD
Celecoxib—Nausea—Methotrexate—bone cancer	7.13e-05	0.000471	CcSEcCtD
Celecoxib—Diarrhoea—Doxorubicin—bone cancer	7.11e-05	0.00047	CcSEcCtD
Celecoxib—Rash—Epirubicin—bone cancer	7.09e-05	0.000468	CcSEcCtD
Celecoxib—Dermatitis—Epirubicin—bone cancer	7.08e-05	0.000467	CcSEcCtD
Celecoxib—MAPK14—Cellular responses to stress—CDK4—bone cancer	7.07e-05	0.000607	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CYP3A4—bone cancer	7.06e-05	0.000607	CbGpPWpGaD
Celecoxib—Headache—Epirubicin—bone cancer	7.04e-05	0.000465	CcSEcCtD
Celecoxib—PDPK1—Immune System—ATF1—bone cancer	7.01e-05	0.000602	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GSTP1—bone cancer	6.98e-05	0.0006	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GSTP1—bone cancer	6.98e-05	0.0006	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—MDM2—bone cancer	6.93e-05	0.000596	CbGpPWpGaD
Celecoxib—Dizziness—Doxorubicin—bone cancer	6.88e-05	0.000454	CcSEcCtD
Celecoxib—CA2—Metabolism—ENO2—bone cancer	6.87e-05	0.00059	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.85e-05	0.000589	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—KIT—bone cancer	6.85e-05	0.000589	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL3—bone cancer	6.83e-05	0.000587	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—JUN—bone cancer	6.8e-05	0.000584	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.79e-05	0.000584	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL3—bone cancer	6.79e-05	0.000584	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.79e-05	0.000583	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL3—bone cancer	6.77e-05	0.000582	CbGpPWpGaD
Celecoxib—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.76e-05	0.000581	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—JUN—bone cancer	6.73e-05	0.000578	CbGpPWpGaD
Celecoxib—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.7e-05	0.000576	CbGpPWpGaD
Celecoxib—Nausea—Epirubicin—bone cancer	6.67e-05	0.000441	CcSEcCtD
Celecoxib—CA4—Metabolism—DHFR—bone cancer	6.65e-05	0.000571	CbGpPWpGaD
Celecoxib—Vomiting—Doxorubicin—bone cancer	6.61e-05	0.000437	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—KIT—bone cancer	6.57e-05	0.000565	CbGpPWpGaD
Celecoxib—Rash—Doxorubicin—bone cancer	6.56e-05	0.000433	CcSEcCtD
Celecoxib—Dermatitis—Doxorubicin—bone cancer	6.55e-05	0.000432	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	6.54e-05	0.000562	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—JUN—bone cancer	6.54e-05	0.000562	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GSTP1—bone cancer	6.52e-05	0.00056	CbGpPWpGaD
Celecoxib—Headache—Doxorubicin—bone cancer	6.51e-05	0.00043	CcSEcCtD
Celecoxib—PDPK1—Signaling by NGF—EGFR—bone cancer	6.46e-05	0.000555	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	6.39e-05	0.000549	CbGpPWpGaD
Celecoxib—CA2—Metabolism—DHFR—bone cancer	6.37e-05	0.000548	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.36e-05	0.000547	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—PTGS2—bone cancer	6.29e-05	0.00054	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—bone cancer	6.28e-05	0.00054	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ATF1—bone cancer	6.25e-05	0.000537	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—KIT—bone cancer	6.24e-05	0.000536	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GNA11—bone cancer	6.21e-05	0.000534	CbGpPWpGaD
Celecoxib—Nausea—Doxorubicin—bone cancer	6.18e-05	0.000408	CcSEcCtD
Celecoxib—PTGS2—Metabolism—NDUFA12—bone cancer	6.15e-05	0.000529	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—RB1—bone cancer	6.14e-05	0.000528	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NR1I2—bone cancer	6.04e-05	0.00052	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GSTP1—bone cancer	6.04e-05	0.000519	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—JUN—bone cancer	6.03e-05	0.000518	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GNA11—bone cancer	5.96e-05	0.000512	CbGpPWpGaD
Celecoxib—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.91e-05	0.000508	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.9e-05	0.000507	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—BRAF—bone cancer	5.86e-05	0.000504	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.86e-05	0.000504	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.85e-05	0.000503	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.81e-05	0.000499	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ENO2—bone cancer	5.79e-05	0.000498	CbGpPWpGaD
Celecoxib—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.78e-05	0.000497	CbGpPWpGaD
Celecoxib—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.73e-05	0.000493	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—bone cancer	5.69e-05	0.000489	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CYP3A4—bone cancer	5.63e-05	0.000484	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.49e-05	0.000472	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CYP3A4—bone cancer	5.4e-05	0.000464	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFBR2—bone cancer	5.4e-05	0.000464	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—MDM2—bone cancer	5.39e-05	0.000464	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MMP9—bone cancer	5.39e-05	0.000463	CbGpPWpGaD
Celecoxib—CA9—Metabolism—DHFR—bone cancer	5.37e-05	0.000462	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SMO—bone cancer	5.33e-05	0.000458	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—bone cancer	5.29e-05	0.000455	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—MDM2—bone cancer	5.24e-05	0.00045	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—bone cancer	5.23e-05	0.00045	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—MDM2—bone cancer	5.18e-05	0.000445	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—bone cancer	5.14e-05	0.000442	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NT5C3A—bone cancer	5.09e-05	0.000438	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PLAU—bone cancer	5.07e-05	0.000436	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GNA11—bone cancer	5.02e-05	0.000431	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—bone cancer	4.98e-05	0.000428	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NDUFA12—bone cancer	4.97e-05	0.000428	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—MDM2—bone cancer	4.91e-05	0.000422	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GNA11—bone cancer	4.87e-05	0.000419	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GSTP1—bone cancer	4.82e-05	0.000414	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—bone cancer	4.71e-05	0.000405	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—JUN—bone cancer	4.69e-05	0.000403	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.64e-05	0.000399	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GSTP1—bone cancer	4.62e-05	0.000397	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—JUN—bone cancer	4.55e-05	0.000391	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CYP3A4—bone cancer	4.55e-05	0.000391	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GRM4—bone cancer	4.53e-05	0.00039	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RGS1—bone cancer	4.53e-05	0.00039	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ATF1—bone cancer	4.53e-05	0.000389	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—EIF2S1—bone cancer	4.46e-05	0.000384	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PLAU—bone cancer	4.44e-05	0.000382	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL3—bone cancer	4.42e-05	0.00038	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	4.37e-05	0.000375	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—bone cancer	4.36e-05	0.000374	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.34e-05	0.000373	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—bone cancer	4.31e-05	0.000371	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MET—bone cancer	4.28e-05	0.000368	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CDK4—bone cancer	4.28e-05	0.000368	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SPARC—bone cancer	4.22e-05	0.000363	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NT5C3A—bone cancer	4.12e-05	0.000354	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NDUFA12—bone cancer	4.11e-05	0.000353	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NDUFA12—bone cancer	4.07e-05	0.00035	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—KIT—bone cancer	3.99e-05	0.000343	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—bone cancer	3.98e-05	0.000342	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GRM1—bone cancer	3.93e-05	0.000338	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.89e-05	0.000335	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GSTP1—bone cancer	3.89e-05	0.000335	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—EZH2—bone cancer	3.88e-05	0.000333	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—GNA11—bone cancer	3.86e-05	0.000332	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.83e-05	0.000329	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.78e-05	0.000325	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFBR2—bone cancer	3.78e-05	0.000325	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.77e-05	0.000324	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—bone cancer	3.71e-05	0.000319	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—bone cancer	3.69e-05	0.000317	CbGpPWpGaD
Celecoxib—PDPK1—Disease—KIT—bone cancer	3.68e-05	0.000317	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—bone cancer	3.66e-05	0.000314	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ATF1—bone cancer	3.64e-05	0.000313	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—bone cancer	3.62e-05	0.000311	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—bone cancer	3.62e-05	0.000311	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP2—bone cancer	3.57e-05	0.000307	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—KIT—bone cancer	3.56e-05	0.000306	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1R—bone cancer	3.56e-05	0.000306	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL3—bone cancer	3.55e-05	0.000305	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—bone cancer	3.54e-05	0.000304	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL3—bone cancer	3.5e-05	0.000301	CbGpPWpGaD
Celecoxib—PDPK1—Disease—BRAF—bone cancer	3.46e-05	0.000298	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—bone cancer	3.44e-05	0.000295	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NT5C3A—bone cancer	3.4e-05	0.000293	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—bone cancer	3.38e-05	0.00029	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NT5C3A—bone cancer	3.37e-05	0.00029	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—bone cancer	3.36e-05	0.000289	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MDM2—bone cancer	3.14e-05	0.00027	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—bone cancer	3.13e-05	0.000269	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—bone cancer	3.01e-05	0.000258	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.96e-05	0.000255	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MDM2—bone cancer	2.9e-05	0.000249	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MDM2—bone cancer	2.8e-05	0.000241	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—bone cancer	2.8e-05	0.00024	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMO—bone cancer	2.77e-05	0.000238	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—JUN—bone cancer	2.73e-05	0.000235	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NDUFA12—bone cancer	2.69e-05	0.000231	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—bone cancer	2.68e-05	0.000231	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ENO2—bone cancer	2.66e-05	0.000229	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—KIT—bone cancer	2.58e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNA11—bone cancer	2.53e-05	0.000218	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—bone cancer	2.5e-05	0.000215	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.49e-05	0.000214	CbGpPWpGaD
Celecoxib—PTGS2—Disease—DHFR—bone cancer	2.47e-05	0.000212	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—JUN—bone cancer	2.44e-05	0.000209	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—BRAF—bone cancer	2.42e-05	0.000208	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—bone cancer	2.39e-05	0.000206	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ATF1—bone cancer	2.35e-05	0.000202	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—bone cancer	2.35e-05	0.000202	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PLAU—bone cancer	2.3e-05	0.000197	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL3—bone cancer	2.3e-05	0.000197	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO2—bone cancer	2.23e-05	0.000192	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NT5C3A—bone cancer	2.22e-05	0.000191	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—bone cancer	2.17e-05	0.000186	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—bone cancer	2.15e-05	0.000185	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—KIT—bone cancer	2.07e-05	0.000178	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DHFR—bone cancer	2.07e-05	0.000178	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—bone cancer	2.04e-05	0.000175	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MDM2—bone cancer	2.03e-05	0.000175	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—bone cancer	2.02e-05	0.000173	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—bone cancer	1.98e-05	0.00017	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFBR2—bone cancer	1.96e-05	0.000169	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNA11—bone cancer	1.93e-05	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—bone cancer	1.92e-05	0.000165	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1R—bone cancer	1.85e-05	0.000159	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO2—bone cancer	1.81e-05	0.000155	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFBR2—bone cancer	1.79e-05	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—bone cancer	1.79e-05	0.000154	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JUN—bone cancer	1.77e-05	0.000152	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP3A4—bone cancer	1.75e-05	0.000151	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—bone cancer	1.72e-05	0.000148	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DHFR—bone cancer	1.67e-05	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MDM2—bone cancer	1.63e-05	0.00014	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNA11—bone cancer	1.57e-05	0.000135	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTP1—bone cancer	1.5e-05	0.000129	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO2—bone cancer	1.49e-05	0.000128	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO2—bone cancer	1.48e-05	0.000127	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000122	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JUN—bone cancer	1.42e-05	0.000122	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.41e-05	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—bone cancer	1.39e-05	0.000119	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DHFR—bone cancer	1.38e-05	0.000119	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DHFR—bone cancer	1.37e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KIT—bone cancer	1.34e-05	0.000115	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNA11—bone cancer	1.29e-05	0.000111	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNA11—bone cancer	1.28e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—BRAF—bone cancer	1.26e-05	0.000108	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KIT—bone cancer	1.22e-05	0.000105	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—bone cancer	1.21e-05	0.000104	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP3A4—bone cancer	1.17e-05	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—bone cancer	1.17e-05	0.0001	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP3A4—bone cancer	1.16e-05	9.99e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.16e-05	9.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—BRAF—bone cancer	1.15e-05	9.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—bone cancer	1.12e-05	9.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MDM2—bone cancer	1.06e-05	9.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—bone cancer	1e-05	8.61e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—bone cancer	9.93e-06	8.54e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO2—bone cancer	9.75e-06	8.38e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MDM2—bone cancer	9.63e-06	8.28e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—bone cancer	9.23e-06	7.93e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JUN—bone cancer	9.17e-06	7.88e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DHFR—bone cancer	9.04e-06	7.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—bone cancer	8.92e-06	7.67e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNA11—bone cancer	8.45e-06	7.26e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—bone cancer	7.21e-06	6.2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—bone cancer	6.58e-06	5.66e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—bone cancer	6.55e-06	5.63e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—bone cancer	6.29e-06	5.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—bone cancer	6.05e-06	5.2e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—bone cancer	5.19e-06	4.46e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—bone cancer	5.15e-06	4.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—bone cancer	3.39e-06	2.92e-05	CbGpPWpGaD
